Skip to main content
Log in

Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The purpose of this study was to determine if botulinum toxin injection at the lower esophageal sphincter improves symptoms in patients with nonachalasia spastic esophageal motility disorders. Fifteen patients with nonachalasia spastic esophageal motility disorders (diffuse esophageal spasm, nonspecific esophageal motility disorders, and lower esophageal sphincter dysfunction) unresponsive to medical therapy underwent endoscopic injection of botulinum toxin at the level of the gastroesophageal junction. Symptoms were scored (0=no symptoms, 1=mild, 2=moderate, 3=severe and 4=very severe) before treatment, at seven days and every 30 days after treatment. There was significant improvement in chest pain, dysphagia, and regurgitation at 7, 30, 60 and 90 days after treatment. At one month after treatment, 11 of 15 (73%) patients had a good or excellent response to treatment. At the last patient interview (mean follow-up of 10.6 months), five (33%) patients continued to have a good to excellent response, whereas 10 (67%) underwent subsequent treatment with repeat botulinum toxin, pneumatic dilation, or bougienage. We conclude that botulinum toxin injection at the gastroesophageal junction leads to significant symptom improvement in patients with nonachalasia esophageal motility disorders. These results suggest that botulinum toxin may be an effective treatment option in some of these patients not responsive to conventional medical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Katz PO, Dalton CB, Richter JE, Wu WC, Castell DO: Esophageal testing in patients with noncardiac chest pain or dysphagia. Ann Intern Med 106:593–597, 1987

    PubMed  Google Scholar 

  2. Achem SR, Kolts BE: Current medical therapy for esophageal motility disorders. Am J Med 92:98S-105S, 1992

    Google Scholar 

  3. Allescher HD, Ravich WJ: Medical treatment of esophageal motility disorders. Dysphagia 8:125–134, 1993

    PubMed  Google Scholar 

  4. Ebert EC, Ouyang A, Wright SH, Cohen S, Lipshutz WH: Pneumatic dilation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci 28:481–485, 1983

    PubMed  Google Scholar 

  5. Nair LA, Reynolds JC, Parkman HP, Rosato EF, Ouyang A, Strom B, Cohen S: Complications of pneumatic dilatation for achalasia or diffuse esophageal spasm. Dig Dis Sci 38:1893–1904, 1993

    PubMed  Google Scholar 

  6. Parischa PJ, Ravich WJ, Hendrix TR, Sostre S, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botu-linum toxin. Ann Intern Med 121:590–591, 1994

    PubMed  Google Scholar 

  7. Pasricha PJ, Ravich WJ, Hendix TR, Sostre S, Jones BI, Kalloo AN: Intransphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 322:774–778, 1995

    Google Scholar 

  8. Hills C, Schiano T, Parkman HP, Dabezies MA, Cohen S, Fisher RS, Miller LS: Botulinum toxin improves symptoms in idiopathic, but not secondary achalasia. Am J Gastroenterol 90:1560, 1995 (abstract)

    Google Scholar 

  9. Reynolds JC, Parkman HP: Achalasia. Gastroenterol Clin North Am 18:223–255, 1989

    PubMed  Google Scholar 

  10. Castell DO: The nutcracker esophagus and other primary esophageal motility disorders.In Esophageal Motility Testing. DO Castell, JE Richter, CB Dalton (eds). New York, Elsevier, 1987, pp 130–142

    Google Scholar 

  11. Klein WA, Parkman HP, Dempsey DT, Fisher RS: Sphincter-like thoracoabdominal high pressure zone in patients after esophagogastrectomy. Gastroenterology 105:1362–1369, 1993

    PubMed  Google Scholar 

  12. Lee CA, Reynolds JC, Ouyang A, Baker L, Cohen S: Esophageal chest pain—value of high dose provocative testing with edrophonium chloride in patients with normal esophageal manometries. Dig Dis Sci 32:682–688, 1993

    Google Scholar 

  13. Katz PO: Disorders of increased esophageal contractility.In The Esophagus. DO Castell (ed). New York, Little Brown, 1991, pp 261–275

    Google Scholar 

  14. Reidel WL, Clouse RE: Variation in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 30:1065–1071, 1985

    PubMed  Google Scholar 

  15. Parkman HP, Maurer AH, Caroline DF, Miller DL, Krevsky B, Fisher RS: Optimal evaluation of patients with nonobstructive esophageal dysphagia: Manometry, scintigraphy, or video-esophagography. Dig Dis Sci 41:1355–1368, 1996

    PubMed  Google Scholar 

  16. Vantrappen G, Hellemans J: Treatment of achalasia and related motor disorders. Gastroenterology 79:144–154, 1980

    PubMed  Google Scholar 

  17. Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S: Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: Clinical outcomes and cost analysis. Dig Dis Sci 38:75–85, 1993

    PubMed  Google Scholar 

  18. Snedecor GW, Cochran GW: Statistical Methods, 7th ed. Ames, Iowa State University Press, 1980

    Google Scholar 

  19. Parischa PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN: Botulinum toxin for achalasia: Long-term outcome and predictors of outcome. Gastroenterology 110:1410–1415, 1996

    PubMed  Google Scholar 

  20. Kao I, Drachman DB, Price DL: Botulinum toxin: Mechanism of presynaptic blockade. Science 193:1256–1258, 1976

    PubMed  Google Scholar 

  21. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC: Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 90:924–929, 1986

    PubMed  Google Scholar 

  22. Parischa PJ, Ravich WJ, Kalloo AN: Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105:1045–1049, 1993

    PubMed  Google Scholar 

  23. DiMarino AJ, Cohen S: Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology 66:1–6, 1974

    PubMed  Google Scholar 

  24. Cattau EL, Jr, Castell DO, Johnson DA, Spurting TJ, Hirszel R, Chobanian SJ, Richter JE: Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 86:272–276, 1991

    PubMed  Google Scholar 

  25. DeVault KR, Castell DO: Esophageal balloon distension and cerebral evoked potentials recording in the evaluation of unexplained chest pain. Am J Med 92:205–265, 1992

    Google Scholar 

  26. Achem SR, Kolts BE, Wears R, Burton L, Richter JE: Chest pain associated with nutcracker esophagus: A preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol 88:187–192, 1993

    PubMed  Google Scholar 

  27. Kahrilas PJ, Clouse RE, Hogan WJ: American Gastroenterological Association Technical Review on the clinical use of esophageal manometry. Gastroenterology 107:1865–1884, 1994

    Google Scholar 

  28. Grande L, Lacima G, Rus E, Pujol A, Garcia-Valdecas JC, Fuster J, Visa J: Dysphagia and esophageal motor dysfunction in gastroesophageal reflux are corrected by fundoplication. J Clin Gastroenterol 13:11–16, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, L.S., Parkman, H.P., Schiano, T.D. et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Digest Dis Sci 41, 2025–2031 (1996). https://doi.org/10.1007/BF02093606

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02093606

Key words

Navigation